Inhibrx Biosciences (INBX) Other Gross PP&E Adjustments (2023 - 2025)
Historic Other Gross PP&E Adjustments for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $8.9 million.
- Inhibrx Biosciences' Other Gross PP&E Adjustments fell 3458.36% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year decrease of 3458.36%. This contributed to the annual value of $7.8 million for FY2024, which is 2362.62% down from last year.
- According to the latest figures from Q3 2025, Inhibrx Biosciences' Other Gross PP&E Adjustments is $8.9 million, which was down 3458.36% from $8.7 million recorded in Q2 2025.
- In the past 5 years, Inhibrx Biosciences' Other Gross PP&E Adjustments ranged from a high of $13.6 million in Q3 2024 and a low of $7.8 million during Q4 2024
- Over the past 3 years, Inhibrx Biosciences' median Other Gross PP&E Adjustments value was $8.9 million (recorded in 2025), while the average stood at $10.0 million.
- Its Other Gross PP&E Adjustments has fluctuated over the past 5 years, first crashed by 2362.62% in 2024, then plummeted by 3458.36% in 2025.
- Over the past 3 years, Inhibrx Biosciences' Other Gross PP&E Adjustments (Quarter) stood at $10.2 million in 2023, then fell by 23.63% to $7.8 million in 2024, then increased by 14.47% to $8.9 million in 2025.
- Its Other Gross PP&E Adjustments stands at $8.9 million for Q3 2025, versus $8.7 million for Q2 2025 and $8.2 million for Q1 2025.